OSA Screen Negative With Spinal Duramorph
Not Applicable
Terminated
- Conditions
- Respiratory Depression
- Interventions
- Device: Capnography monitoring
- Registration Number
- NCT03151226
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
Non emergent scheduled cesarean sections will be consented to participate in this study of patients who have screened negative for obstructive sleep apnea and who are also BMI\>/= 35 to have capnography monitoring postoperatively. The capnography and pulse oximetry will be initiated in the post anesthesia care unit and be worn for 12-24 hours after delivery. Data will be retrieved after that time period in a deidentified fashion. Medication usage will be reviewed as well as the standard of care information from the duramorph monitoring will be retrieved.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 3
Inclusion Criteria
- OSA screen negative per hospital protocol
- age 18 or greater
- BMI>35
- consent to participate to wear capnography and pulse oximetry monitoring devices post delivery
Read More
Exclusion Criteria
- Spanish speaking only
- under age 18
- contraindication to receiving drugs utilized in delivery anesthetic
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description capnography monitoring Capnography monitoring single arm, all subjects receiving duramorph will receive capnography monitoring
- Primary Outcome Measures
Name Time Method Respiratory Depression/Suppression up to 24 hours defined by values obtained utilizing capnography and pulse oximetry
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Novant Health Forsyth Medical Center
🇺🇸Winston-Salem, North Carolina, United States